Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Y
|
Yoma Strategic Holdings Ltd
XBER:O3B
|
SG |
|
H
|
HSBC Holdings PLC
OTC:HBCYF
|
UK |
|
Electrolux Professional AB (publ)
STO:EPRO B
|
SE |
|
Sos Ltd
NYSE:SOS
|
CN |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
S
|
Sepeda Bersama Indonesia Tbk PT
IDX:BIKE
|
ID |
Zhejiang Anglikang Pharmaceutical Co Ltd
Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceutical drugs. The company is headquartered in Shaoxing, Zhejiang and currently employs 881 full-time employees. The company went IPO on 2018-10-23. is a China-based company principally engaged in the research, development, production and sales of chemical raw materials and preparations. The firm's products mainly include cephalosporin and penicillin series, anti-hypertension series, digestive system series, kidney disease series and others.
Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceutical drugs. The company is headquartered in Shaoxing, Zhejiang and currently employs 881 full-time employees. The company went IPO on 2018-10-23. is a China-based company principally engaged in the research, development, production and sales of chemical raw materials and preparations. The firm's products mainly include cephalosporin and penicillin series, anti-hypertension series, digestive system series, kidney disease series and others.
